Monitoring Low Molecular Weight Heparins at Therapeutic Levels: Dose-Responses of, and Correlations and Differences between aPTT, Anti-Factor Xa and Thrombin Generation Assays

Eitemau Tebyg

• Monitoring low molecular weight heparins at therapeutic levels: dose-responses of, and correlations and differences between aPTT, anti-factor Xa and thrombin generation assays.
  gan: Owain Thomas, et al.
  Cyhoeddwyd: (2015-01-01)
• Thromboelastometry versus free-oscillation rheometry and enoxaparin versus tinzaparin: an in-vitro study comparing two viscoelastic haemostatic tests’ dose-responses to two low molecular weight heparins at the time of withdrawing epidural catheters from ten patients after major surgery
  gan: Thomas, Owain, et al.
  Cyhoeddwyd: (2015)
• Establishing the heparin therapeutic range using aPTT and anti-Xa measurements for monitoring unfractionated heparin therapy
  gan: Byun, Jung-Hyun, et al.
  Cyhoeddwyd: (2016)
• Discordance and bleeding in critically ill patients with COVID-19 receiving unfractionated heparin: A comparison between aPTT and anti-factor Xa activity level monitoring
  gan: Merijn C. Reuland, et al.
  Cyhoeddwyd: (2025-06-01)
• Monitoring Anticoagulation with Unfractionated Heparin on Renal Replacement Therapy. Which is the Best aPTT Sampling Site?
  gan: Anton, Florin Ioan, et al.
  Cyhoeddwyd: (2020)